OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
1-Year Return
84.31%
This Quarter Return
-3.83%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$723M
AUM Growth
-$101M
(-12%)
Cap. Flow
-$37.7M
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
78.48%
Holding
32
New
2
Increased
9
Reduced
7
Closed
4
Top Buys
| 1 |
CMRX
Chimerix, Inc.
CMRX
|
$16.6M |
| 2 |
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
|
$7.65M |
| 3 |
BIOL
Biolase, Inc.
BIOL
|
$5.66M |
| 4 |
YTEN
Yield10 Bioscience, Inc. Common Stock
YTEN
|
$3.24M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$1.89M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$24.8M |
| 2 |
Tenet Healthcare
THC
|
$12.7M |
| 3 |
GTIV
GENTIVA HEALTH SERVICES INC
GTIV
|
$9.07M |
| 4 |
BLUE
bluebird bio
BLUE
|
$6.9M |
| 5 |
THOR
THORATEC CORPORATION
THOR
|
$6.53M |
Sector Composition
| 1 | Healthcare | 79.28% |
| 2 | Consumer Staples | 0.66% |
| 3 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celldex Therapeutics
CLDX
$1.51B
| $324K | 0.04% |
+1,667
| New | +$324K |
|
|
ONCT
27
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $196K | 0.03% |
189
| – | – |
|
|
BLUE
28
DELISTED
bluebird bio
BLUE
| – | – |
-13,814
| Closed | -$6.9M |
|
29
Gilead Sciences
GILD
$140B
| – | – |
-50,000
| Closed | -$4.15M |
|
|
30
Ironwood Pharmaceuticals
IRWD
$179M
| – | – |
-1,935,361
| Closed | -$24.8M |
|
31
Tonix Pharmaceuticals
TNXP
$231M
| – | – |
0
| – | -$1.32M |
|
|
GTIV
32
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| – | – |
-601,960
| Closed | -$9.07M |
|